Pt Bundamedik Tbk · IDX:BMHS

Pt Bundamedik Tbk — Q1 2022 Earnings Presentation

22 slides from Pt Bundamedik Tbk's earnings presentation, May 2022

  1. Slide 1: PT Bundamedik Tbk Investor Presentation – 1Q22 Results

    PT Bundamedik Tbk Investor Presentation – 1Q22 Results May 2022 Disclaimer: Presentation are intended for educational purposes only and do not replace independent professional judgement. Statements of fact and opinions are those of the participants individually and, unless expressly stated to the co

  2. Slide 2: Bundamedik Tbk (BMHS) Ecosystem

    Bundamedik Tbk (BMHS) Ecosystem Expanding Presence RSIA Az Zahra 8 HOSPITALS + 3 CLINICS Women & Children Hospitals 10 IVF CLINICS PADANG PONTIANAK BATAM 38 LABORATORIES Bunda Hospitals PALEMBANG MAKASSAR CLINICS NETWORK 152 (KLINIK PINTAR) YOGYAKARTA 126 FERTILITY CLINICS NETWORK (KFI) Jakarta Depo

  3. Slide 3: 1Q22 Results

    1Q22 Results Expanding 1Q22 Results Presence Strategic Strengthening Partnership Our Core

  4. Slide 4: Financial & Operational Performance

    Financial & Operational Performance Improving Non-Covid Business HIGHLIGHTS OF CONSOLIDATED RESULT HIGHLIGHTS HIGHLIGHTS 4Q21 1Q22 QoQ (%) 1Q21 YoY (%) OPERATIONALS ('000) 1 Significant growth on inpatient volume QoQ performance # Outpatient 105,5 107,8 2% 94,0 15% (inpatient days +23% QoQ, -6% YoY;

  5. Slide 5: Financial Performance

    Financial Performance Consolidated REVENUE GROSS PROFIT (Rp B) (Rp B,%) +33% +34% 824 1.711 1.148 457 493 -10% 965 0,3% 48% 450 47% 43% 225 180 162 388 389 46% 42% 50% 2019 2020 2021 1Q21 4Q21 1Q22 2019 2020 2021 1Q21 4Q21 1Q22 EBITDA 1) NET INCOME (Rp B,%) (Rp B,%) +58% 460 315 +217% 224 +15% +26%

  6. Slide 6: Balance Sheet

    Balance Sheet Debt increase with expansion of two new hospitals CASH VS DEBT* DEBT-TO-EBITDA Gross Net (Rp B) (x) Net 430 417 -135 73 Debt 794 5.2x 785 2,2x 2,2x 712 2,0x 625 613 1,3x 518 490 0,2x 100 -0,6x -0,4x 2019 2020 2021 1Q22 3M22 2019 2020 2021 1Q22 3M22 AR Days WORKING CAPITAL DAYS Inventor

  7. Slide 7: Higher contributions from core business offset covid decline

    Higher contributions from core business offset covid decline QUARTERLY REVENUE (Rp B) NON-COVID REVENUE Covid 25% SECOND WAVE DELTA WAVE QoQ Non-Covid Non Covid *) FIRST WAVE +6% Rp 1,069 BN Rp 1,337 BN 451 452 389 FY 2020 FY 2021 420 388 14 348 118 116 334 107 33 *) 18 54 +27% 262 203 4Q YoY Non-Co

  8. Slide 8: Post Omicron, Strong Rebound IVF Cycles in Mar-22

    Post Omicron, Strong Rebound IVF Cycles in Mar-22 -10% # OF IVF CYCLES (‘000) 1,6 Outside Jakarta 1,5 Jakarta 1,4 Surabaya vs QoQ 0,6 0,6 +2% 0,6 +36% 0,5 0,5 0,5 0,5 0,5 0,5 0,5 0,5 0,4 0,4 0,4 0,3 -13% -55% Jan-21 Feb-21 Mar- Apr-21 May- Jun-21 Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21 Jan-22 Feb-

  9. Slide 9: Diagnos: Transitioning to Non-Covid Tests

    Diagnos : Transitioning to Non-Covid Tests # OF TESTS (‘000) +38% Covid Non Covid 265 104 84 85 83 78 191 191 75 64 63 64 61 60 54 51 50 55 +24% Non Covid Test in QoQ Jan- Feb- Mar- Apr- May- Jun- Jul- Aug- Sep- Oct- Nov- Dec- Jan- Feb- Mar- 1Q21 4Q21 1Q22 21 21 21 21 21 21 21 21 21 21 21 21 22 22 2

  10. Slide 10: Expanding Presence

    Expanding Presence Expanding Strong FY 2021 1Q22 Results Presence Results Strategic Strengthening Partnership Our Core

  11. Slide 11: Expanding Presence

    Expanding Presence # OF DIAGNOS LABS # OF HOSPITAL BEDS Covid 38 Non Covid 506 34 478 441 414 387 133 168 340 336 196 15 16 193 181 120 7 3 345 338 216 221 245 206 2018 2019 2020 2021 1Q21 1Q22 4Q19 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 DOUBLE IN NUMBER OF OUTLETS

  12. Slide 12: RSJP Paramarta – Cardiac Hospital (Bandung)

    Expanding Presence RSJP Paramarta – Cardiac Hospital (Bandung) Bed Capacity Doctors Consultation Room Surgery Room Ownership 36 beds 11 Specialists 9 GPs 6 Rooms 2 + 3 Rooms 35%

  13. Slide 13: RSU Citra Harapan - Bekasi

    Expanding Presence RSU Citra Harapan - Bekasi Bed Capacity Doctors Consultation Room Surgery Room Ownership 104 beds >25 Specialists & GPs 13 Rooms 3 Rooms 100%

  14. Slide 14: Strengthening Our Core

    Strengthening Our Core Expanding 1Q22 Results Strong FY 2021 Presence Results Strategic Strengthening Partnership Our Core

  15. Slide 15: Revamping Customer Journey

    Revamping Customer Journey 1 Define the end-state patient journey 4 Developed implementation plans for customers and Bunda to launch the pilots 2 Identified improvement initiatives 3 Prioritized initiatives required to achieve the end-state to be piloted 15

  16. Slide 16: 9 pilot teams in RSIA have been mobilized

    9 pilot teams in RSIA have been mobilized for customer experience enhancement Pilot teams kick off with pilot leader Initiative teams meeting to discuss progress Pilot teams and initiative leaders daily task Teramedik clinical superuser training in prioritization in RSIA pilot room preparation for a

  17. Slide 17: Booking Apps

    Booking Apps ehealth.bunda.co.id 17

  18. Slide 18: Continuous Improvement on Patient Satisfaction

    Continuous Improvement on Patient Satisfaction (1 = very unsatisfied; 5 = very satisfied) YTD W3 Mar22 Booking 3.9 4.0 Appointment 3.9 4.1 Doctor 4.3 4.5 Consultations

  19. Slide 19: Strategic Partnership

    Strategic Partnership Expanding 1Q22 Results Presence Strong FY 2021 Results Strategic Strengthening Partnership Our Core

  20. Slide 20: Enhancing Our Ecosystem: Klinik Fertilitas Indonesia (KFI)

    Enhancing Our Ecosystem : Klinik Fertilitas Indonesia (KFI) Morula strong presence through Partnership with local Obgyn extensive KFI networks clinics • Efficient way to scale up 126 KFI +26% Morula’s business Clinics Vs 4Q21 • Promote Morula’s branding across Indonesia • Increase referrals from obg

  21. Slide 21: 2022 Strategic Focus

    2022 Strategic Focus Network Expansion • Additional 2-3 Hospitals Expanding Our Ecosystem • Additional 1-2 Morula Centre, 30% growth in KFI Clinics • Additional 20 Diagnos Outlets Deepening our relationship and business development with our Strategic Partnership strategic partners, government and sc

  22. Slide 22: Thank You

    THANK YOU Disclaimer: Presentation are intended for educational purposes only and do not replace independent professional judgement. Statements of fact and opinions are those of the participants individually and, unless expressly stated to the contrary. Specific data in this presentation was obtaine

PT Bundamedik — Q1 2022 Earnings Presentation on 6ix